Clinical Trial Update: Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating sequential CD5/CD7-specific CAR-T cells for CD5/CD7-positive T-cell malignancies including T-cell acute lymphobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia Pediatric
• Peripheral T-cell Leukemia
• Peripheral T-cell Lymphoma
• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma
• T-cell Lymphoma of the Central Nervous System
• T-cell Prolymphocytic Leukemia

Drugs mentioned

• CD5/CD7 CAR-T cells (CD5/CD7-targeted CAR-T cells)

Snippet

Sponsor: Essen Biotech | Conditions: T Cell Lymphoma, T Cell Leukemia | Phase 1, Phase 2 | Status: RECRUITING